增长差异化因子-15预测癌症患者的主要出血:来自维也纳猫血研究的结果
Cornelia Englisch1, Stephan Nopp1, Florian Moik2
1Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria.
JACC. CardioOncology
|February 19, 2025
概括
增长差异化因子 (GDF) -15水平可以预测癌症患者的主要出血风险. 这一发现为评估瘤治疗中的出血并发症提供了一个有希望的新生物标志物.
科学领域:
- 在瘤学瘤学.
- 血液学 血液学 血液学
- 生物标志物发现发现
背景情况:
- 静血系统与癌症密切相关,但出血风险的预测仍然不如血栓性并发症.
- 增长差异化因子 (GDF) -15已经成为出血事件的潜在预后生物标志物.
研究的目的:
- 调查GDF-15水平与癌症患者出血风险之间的关联.
- 评估GDF-15对重大出血事件的预测能力.
主要方法:
- 779名癌症患者开始全身抗癌治疗的前性观察队列研究 (CAT-BLED).
- 随访时间长达2年,监测主要出血和血栓事件.
- 在基线,3个月和6个月测量GDF-15水平.
主要成果:
- 较高的GDF-15水平独立地与较大的出血风险增加有关 (每倍的aHR为1.29).
- 超过中位数的GDF-15患者的12个月累积大出血发生率显著更高 (13.1%与4.6%相比).
- 在预测6个月大出血风险 (C-统计=0.69) 方面,GDF-15显示出中等到良好的区别.
结论:
- GDF-15水平有效预测癌症患者的主要出血风险.
- GDF-15与静脉血栓栓塞不相关,突出显示其对出血风险的特异性.
- GDF-15是一种有前途的生物标志物,用于预测瘤学环境中的出血风险.
更多相关视频
10:21Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
Published on: February 21, 2018
9.9K
08:48An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation
Published on: June 30, 2015
8.2K
相关概念视频
Role of Hematopoietic Growth Factors
1.2K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.2K
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K
